Home Halogens disodium 2-[(2-carboxylatophenyl)amino]-4-chlorobenzoate

disodium 2-[(2-carboxylatophenyl)amino]-4-chlorobenzoate

CAS No.:
64808-48-6
Catalog Number:
AG00EFVM
Molecular Formula:
C14H10ClNO4
Molecular Weight:
291.6865
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
5mg
95%
In Stock USA
United States
$73
- +
25mg
95%
In Stock USA
United States
$141
- +
100mg
95%
In Stock USA
United States
$375
- +
Product Description
Catalog Number:
AG00EFVM
Chemical Name:
disodium 2-[(2-carboxylatophenyl)amino]-4-chlorobenzoate
CAS Number:
64808-48-6
Molecular Formula:
C14H10ClNO4
Molecular Weight:
291.6865
MDL Number:
MFCD00941422
IUPAC Name:
disodium;2-(2-carboxylatoanilino)-4-chlorobenzoate
InChI:
InChI=1S/C14H10ClNO4.2Na/c15-8-5-6-10(14(19)20)12(7-8)16-11-4-2-1-3-9(11)13(17)18;;/h1-7,16H,(H,17,18)(H,19,20);;/q;2*+1/p-2
InChI Key:
QPJBONAWFAURGB-UHFFFAOYSA-L
SMILES:
Clc1ccc(c(c1)Nc1ccccc1C(=O)O)C(=O)O
UNII:
7Z9SP74BXF
Properties
Complexity:
365  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
3  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
334.994g/mol
Formal Charge:
0
Heavy Atom Count:
22  
Hydrogen Bond Acceptor Count:
5  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
335.651g/mol
Monoisotopic Mass:
334.994g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
92.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
Title Journal
Identifying mechanism-of-action targets for drugs and probes. Proceedings of the National Academy of Sciences of the United States of America 20120710
Estimation of the percolation thresholds in ternary lobenzarit disodium-dextran-HPMC hydrophilic matrices tablets: effects of initial porosity. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20091105
Investigation of the influence of particle size on the excipient percolation thresholds of HPMC hydrophilic matrix tablets. Journal of pharmaceutical sciences 20071001
Estimation of the percolation thresholds in lobenzarit disodium native dextran matrix tablets. AAPS PharmSciTech 20071001
Study of the critical points in lobenzarit disodium hydrophilic matrices for controlled drug delivery. Chemical & pharmaceutical bulletin 20060501
Application of a new mathematical method for the estimation of the mean surface area to calculate the percolation threshold of lobenzarit disodium [correction of dissodium] salt in controlled release matrices. Chemical & pharmaceutical bulletin 20040701
Alpha-methyldopa-type autoimmune hemolytic anemia caused by lobenzarit disodium of a mefenamic acid derivative and immunomodulator. Blood 19940515
Properties